ADVENT is a global medical education program by Sanofi and Regeneron. This website is intended for Healthcare Professionals based in the United Kingdom only. This platform contains product information. Adverse event reporting statement and prescribing information can be found at the bottom of the page.

Contact an MSL

This section is to contact your local field representative for Sanofi or Regeneron. To report any adverse events, please visit: ae.reporting.sanofi

  • Allergology
  • Allergy
  • Allergy and Immunology
  • Cardiology
  • Dermatology
  • Endocrinology
  • Gastroenterology
  • Hematology
  • Immunology
  • Internal Medicine
  • Nephrology and Oncology
  • Neurology
  • Ophthalmology
  • Otolaryngology (ENT)
  • Pediatric and Other
  • Psychiatry
  • Pulmonology
  • Rheumatology
  • England: East
  • England: London
  • England: Midlands
  • England: North East
  • England: North West
  • England: South West
  • England: South East
  • Northern Ireland
  • Wales
Preferred method of communication:

ADVENT is a global medical education program by Sanofi and Regeneron. This website is intended for Healthcare Professionals based in the United Kingdom only.

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to the Sanofi drug safety department on Tel: 0800 0902 314. Alternatively, send via email to UK-drugsafety@sanofi.com.

This platform contains product information and you can find the link for the Prescribing Information below.


Dermatology PI   Asthma PI  COPD PI  CRSwNP PI

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-XU-2501251 (v1.0) Date of preparation July 2025

All Rights Reserved.
Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United KingdomChange country/region